Product name | Recombinant SARS-CoV-2 Nucleocapsid Protein with His tag |
---|---|
Catalog No. | RP01264 |
Description | Recombinant SARS-CoV-2(2019-nCoV) Nucleocapsid Protein is produced by E. coli expression system. The target protein is expressed with sequence (Met1-Ala419) of SARS-COV-2(2019-nCoV) Nucleocapsid (Accession #QHD43423.2) fused with an 6×His tag at the N-terminus. |
Bio-Activity | Measured by its binding ability in a functional ELISA. Immobilized Recombinant SARS-CoV-2 Nucleocapsid at 2μg/mL (100 μL/well) can bind Anti-Nucleocapsid antibody with a linear range of 0.12-1.64 ng/mL. Measured by its binding ability in a functional ELISA. Immobilized Recombinant SARS-CoV-2 envelope Protein at 2μg/mL (100 μL/well) can bind Recombinant SARS-CoV-2 Nucleocapsid protein, the EC50 of Recombinant SARS-CoV-2 Nucleocapsid protein is 41.10 ng/mL. |
Purity | > 95% by SDS-PAGE;> 95% by HPLC. |
Endotoxin | < 1.0 EU/μg of the protein by LAL method. |
Formulation | Supplied as a 0.22 μm filtered solution in 20mM Tris, 500mM NaCl, 0.1mM EDTA, 10% glycerol, pH8.0.Contact us for customized product form or formulation. |
Species | SARS-CoV-2 |
Calculated MW | 49.4kDa |
Synonym | Nucleoprotein |
---|---|
Expression Host | E. coli |
Tag | N-6×His |
Gene ID |
Storage | Store at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt. After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week. |
---|
* For research use only. Not for therapeutic or diagnostic purposes.
Publishing research using RP01264? Please let us know so that we can cite the reference in this datasheet.
!OUT OF STOCK
See Below for Alternatives